| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
65,958 |
65,370 |
$10.82M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,863 |
22,692 |
$5.33M |
| D9999 |
Unspecified adjunctive procedure, by report |
5,515 |
5,513 |
$4.99M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,654 |
10,594 |
$3.53M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,417 |
12,282 |
$1.59M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,676 |
8,631 |
$863K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
838 |
837 |
$385K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,313 |
4,292 |
$330K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,228 |
1,061 |
$304K |
| 36415 |
Collection of venous blood by venipuncture |
41,672 |
40,389 |
$277K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
36,934 |
34,669 |
$246K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,185 |
3,993 |
$180K |
| 80053 |
Comprehensive metabolic panel |
18,705 |
17,920 |
$167K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,829 |
3,732 |
$152K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,080 |
1,080 |
$147K |
| 71045 |
Radiologic examination, chest; single view |
10,838 |
10,777 |
$139K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
27 |
27 |
$90K |
| 95819 |
|
278 |
278 |
$78K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
565 |
563 |
$76K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
735 |
734 |
$72K |
| 87400 |
|
2,852 |
2,842 |
$69K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,131 |
1,082 |
$60K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
360 |
360 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,136 |
8,064 |
$44K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
241 |
241 |
$43K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
67 |
67 |
$38K |
| 71046 |
Radiologic examination, chest; 2 views |
2,194 |
2,190 |
$37K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,106 |
4,924 |
$37K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,682 |
5,340 |
$36K |
| 70450 |
Computed tomography, head or brain; without contrast material |
737 |
735 |
$36K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
787 |
782 |
$36K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
82 |
82 |
$33K |
| 81001 |
|
10,053 |
9,920 |
$31K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
831 |
831 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
404 |
389 |
$23K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
85 |
84 |
$20K |
| 87522 |
Neg quan hep c or qual rna |
464 |
421 |
$18K |
| 83690 |
|
3,111 |
3,067 |
$18K |
| 87430 |
|
1,228 |
1,227 |
$18K |
| 84484 |
|
1,430 |
1,265 |
$16K |
| 87070 |
|
1,122 |
1,122 |
$16K |
| 81025 |
|
1,872 |
1,858 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
486 |
486 |
$13K |
| 97597 |
|
518 |
290 |
$10K |
| 93975 |
|
99 |
99 |
$9K |
| 85027 |
|
1,617 |
1,607 |
$8K |
| 82657 |
|
477 |
477 |
$8K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
240 |
65 |
$7K |
| 81003 |
|
3,498 |
3,480 |
$7K |
| 84703 |
|
1,091 |
1,086 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
142 |
142 |
$6K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
60 |
60 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
82 |
79 |
$6K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
122 |
121 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
447 |
401 |
$5K |
| 88312 |
|
87 |
87 |
$5K |
| A4222 |
Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) |
319 |
315 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
344 |
343 |
$5K |
| 83735 |
|
672 |
637 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
522 |
518 |
$3K |
| 83880 |
|
104 |
103 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
531 |
486 |
$3K |
| 95811 |
|
12 |
12 |
$3K |
| 87420 |
|
228 |
227 |
$3K |
| 80143 |
|
173 |
172 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
85 |
85 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
85 |
85 |
$3K |
| 31622 |
|
13 |
13 |
$3K |
| 80179 |
|
161 |
160 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
14 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,989 |
2,824 |
$2K |
| 82803 |
|
100 |
95 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
27 |
27 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,815 |
5,003 |
$2K |
| 87081 |
|
306 |
305 |
$2K |
| 74183 |
|
26 |
26 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13 |
13 |
$2K |
| 83605 |
|
140 |
128 |
$1K |
| 82330 |
|
95 |
93 |
$1K |
| 74019 |
|
45 |
45 |
$908.88 |
| 84702 |
|
58 |
57 |
$723.50 |
| 85610 |
|
189 |
181 |
$675.77 |
| 82565 |
|
139 |
137 |
$630.41 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12 |
12 |
$594.03 |
| 81002 |
|
177 |
175 |
$533.20 |
| 74018 |
|
31 |
31 |
$508.37 |
| 86140 |
|
110 |
110 |
$488.66 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
183 |
183 |
$439.51 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
38 |
38 |
$385.40 |
| 84295 |
|
75 |
73 |
$350.44 |
| 82947 |
|
96 |
94 |
$329.97 |
| 84520 |
|
85 |
83 |
$294.84 |
| 84132 |
|
64 |
63 |
$274.95 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
432 |
377 |
$265.74 |
| 82374 |
|
40 |
40 |
$177.94 |
| 82977 |
|
23 |
21 |
$161.68 |
| 85014 |
|
74 |
72 |
$158.25 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
55 |
55 |
$133.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
56 |
48 |
$114.00 |
| 82435 |
|
25 |
25 |
$102.25 |
| 87075 |
|
13 |
13 |
$92.62 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
64 |
51 |
$55.12 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
952 |
910 |
$44.40 |
| 87205 |
|
13 |
13 |
$41.80 |
| A6457 |
Tubular dressing with or without elastic, any width, per linear yard |
13 |
13 |
$38.28 |
| A4215 |
Needle, sterile, any size, each |
43 |
43 |
$27.51 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
13 |
$18.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
838 |
815 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
32 |
31 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
581 |
500 |
$0.00 |
| 99152 |
|
292 |
281 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
24 |
24 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
88 |
85 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
30 |
30 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,949 |
2,143 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
955 |
683 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
44 |
44 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
15 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
26 |
13 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
60 |
58 |
$0.00 |